Bird Flu Diagnosis
Below is a MRR and PLR article in category Health Fitness -> subcategory Disease Illness.
Bird Flu: Diagnosis
Dealing with bird flu effectively hinges on accurate diagnosis. Many upper respiratory infections present similar early symptoms, such as those of the common cold, seasonal flu, and bird flu itself. Symptoms like fever, cough, malaise, nausea, vomiting, and diarrhea make it challenging to distinguish between seasonal and bird flu. Accurate diagnosis is crucial for appropriate treatment and the initiation of infection control and public health measures.
Presently, diagnosing bird flu and similar viral infections is challenging. It requires specialized testing, which is both time-consuming and only available in a few advanced laboratories. However, advancements in this area offer hope for improved testing methods soon.
Richard Janeczko, Ph.D., executive vice-president and chief scientific officer at Tm Bioscience, a Toronto-based company, has announced significant progress in developing a sophisticated diagnostic test. This test will not only identify bird flu but also differentiate more than 15 other viral infections, including SARS, which can mimic bird flu symptoms.
The Multiplexed Respiratory Test can distinguish between influenza A and B, and identify the H5 subtype of influenza A (bird flu is H5N1), among other H subtypes. It can also detect various common and uncommon viruses responsible for flu-like illnesses, which is vital for managing patient care, community health, and economic factors. Many existing tests struggle with clinical sensitivity and specificity, leading to false positives and negatives. Misdiagnosing an H5N1 outbreak can result in unnecessary antiviral treatments, unwarranted vaccination efforts, and adverse economic impacts, such as unwarranted poultry culling. Conversely, a false negative could have catastrophic consequences, potentially leading to a pandemic.
This test uses nasal swab specimens and delivers results in less than five hours, intended for hospital diagnostic and infection control applications. The assay is under expedited review by the Food and Drug Administration (FDA), with TM Bioscience aiming for FDA clearance by January 2006. If successful, this test could have significant global applications, potentially saving many lives.
Bradford Frank, M.D., M.P.H., M.B.A.
The Frank Group
P.O. Box 138
Lakewood, NY 14750
http://www.AvoidBirdFlu.com
You can find the original non-AI version of this article here: Bird Flu Diagnosis.
You can browse and read all the articles for free. If you want to use them and get PLR and MRR rights, you need to buy the pack. Learn more about this pack of over 100 000 MRR and PLR articles.